Follow-The-Filings

Security

AQST

Aquestive Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

9 owners 2 new 1 exit max 0.0% (Dmitry Balyasny - Balyasn...)

grid → activity →
owners 9
max % 0.0%
tracked value $57M
qoq N 2 A 2 R 4 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% Add +0.01 pp 2,900,570 $12M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 5,892,334 $38M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 381,120 $2M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 565,203 $2M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% New 0.0% 283,734 $1M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Reduce 0.00 pp 51,594 $214 hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 25,851 $107 hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% New 0.0% 18,315 $76 hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce 0.00 pp 18,149 $75 hist
Renaissance Technologies LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 414,400 $3M hist

9 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $50.58M $57.56M $44.54M
Gross profit * $29.75M $39.69M $25.99M
Gross margin * 58.8% 69.0% 58.3%
Net income -$7.87M -$44.14M -$83.78M
Net margin * -15.6% -76.7% -188.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $40.97M $88.22M $149.27M
Total non-current assets * $16.45M $13.2M $11.16M
Total assets $57.42M $101.42M $160.42M
Total current liabilities $18.31M $18.86M $47.61M
Total non-current liabilities * $145.6M $142.72M $146.48M
Total equity -$106.49M -$60.16M -$33.66M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$6.38M -$35.76M -$52.43M
Cash from investing -$995,000 -$159,000 -$562,000
Cash from financing $3.97M $83.59M $102.62M
Net change in cash -$3.4M $47.67M $49.62M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders